Dr. Grabowski Explains the Effects of Enzyme Therapy

Published: Saturday, Jan 14, 2012

Gregory A. Grabowski, MD, professor, University Cincinnati, Department of Pediatrics, director, Division of Human Genetics, director, Medical Genetics Training Program, Cincinnati Children's Hospital Medical Center, discusses the immense benefit that enzyme therapy provides to patients with Gaucher disease, a debilitating lysosomal storage disease.

Gregory A. Grabowski, MD, professor, University Cincinnati, Department of Pediatrics, director, Division of Human Genetics, director, Medical Genetics Training Program, Cincinnati Children's Hospital Medical Center, discusses the immense benefit that enzyme therapy provides to patients with Gaucher disease, a debilitating lysosomal storage disease.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x